NEW YORK, Sept. 8, 2023 /PRNewswire/ — The Duchenne muscular dystrophy (DMD) therapeutics market size is expected to grow by USD 2.39 billion from 2022 to 2027. In addition, the momentum of the market will progress at a CAGR of 21.2% during the forecast period, according to Technavio…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.